Historically, mouse models for FSHD have had limited experimental use due to either severe phenotypes preventing long-term studies or a lack of detectable DUX4 expression and muscle pathologies [25,44,45,46,47]. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.